http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2912612-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_442519b1c08867cccfb1e54fa4fc6654 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
filingDate | 2018-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db4170d263edeb73bd1d02a9f24a8944 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d08bae701fae902323e2c6363d2ad201 |
publicationDate | 2022-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2912612-T3 |
titleOfInvention | 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives |
abstract | Derivatives of 2-oxo-1-pyrrolidinyl imidazothiadiazole according to formula (I), their geometric isomers, enantiomers, diastereomers, isotopes and mixtures, or a pharmaceutically acceptable salt thereof, **(See formula)** where R1 is a C1-4 alkyl optionally substituted with one or more halogen substituents; R2 is C1-4 alkyl containing at least one hydroxy or alkoxy substituent; and R3 is a methyl (including -CD3). |
priorityDate | 2017-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 164.